# Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

> **NCT00233636** · PHASE2 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 28 (—)

## Conditions studied

- Head and Neck Cancer
- Carcinoma, Squamous Cell

## Interventions

- **DRUG:** Iressa (Gefitinib)
- **PROCEDURE:** Radiotherapy

## Key facts

- **NCT ID:** NCT00233636
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 28 (—)
- **Last updated:** 2011-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233636, "Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00233636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*